Under normal conditions, brain tissue PO 2 is reported to be in the range 3.3-5.2 kPa in animals and patients. [1] [2] [3] Tissue oxygenation may be inhibited by cerebral occlusive disease or by arterial venous malformations (AVM), which attenuate cerebral perfusion pressure by producing a low resistance shunt for blood flow. [4] [5] [6] It has been reported that the upper limit of tissue oxygenation is controlled in normal brain tissue during oxygen ventilation, but that these regulating mechanisms are missing after head injury. 3 Little is known of tissue changes in PO 2 during hyperoxia in tissue affected by occlusive disease or AVM. The purpose of this study was to evaluate the effect of oxygen ventilation in patients with cerebral occlusive disease and AVM compared with non-ischaemic controls.
Patients and methods
The studies were approved by the University of Illinois Institutional Review Board for Clinical Research and informed consent was obtained. Patients in group 1 (n:9) served as controls for the study. None of these patients bled or had clinical signs of ischaemia before surgery. Neurosurgery was performed in these patients for clipping of cerebral aneurysms. Patients in group 2 (n:11) had evidence of cerebral ischaemia, as determined by neurological examination or the presence of transient ischaemic episodes. Decreased regional cerebral perfusion was confirmed in these patients by single photon emission computed tomography (SPECT) or cerebral angiography. Six of these patients were undergoing extracerebral to intracerebral vascular bypass, two patients cerebral aneurysm surgery with confirmed cerebral vasospasm and three patients had a cerebral embolism. Patients in group 3 (n:12) were undergoing neurosurgery for AVM resection. Nine of these patients had previous neuroradiological AVM embolization procedures performed before AVM resection.
All 
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for measurement of PCO 2 and pH, a miniaturized Clark electrode for PO 2 measurement and a thermocouple for measurement of temperature. The sensor was calibrated with three precision gases supplied with the monitor before insertion into the patient. The gases are: 1:2% carbon dioxide, 15% oxygen, balance nitrogen; 2:5% carbon dioxide, 15% oxygen, balance nitrogen; 3:10% carbon dioxide, 15% oxygen, balance nitrogen. The calibration range and 95% confidence limits for each sensor have been determined in in vitro testing: oxygen (range 0-15.7 kPa, 95% confidence limits ;0.1 kPa); carbon dioxide (range 1.3-10.5 kPa, 95% confidence limits ;0.4 kPa); pH (range 6.80-7.80, 95% confidence limits ;0.03). The 0% to 90% response time for each sensor is: oxygen:70 s, carbon dioxide:143 s, pH:78 s. 7 All monitored variables were collected by computer using Labview (National Instruments, Austin, TX) every 10 s.
When the sensor was inserted, baseline tissue gas tensions, pH and temperature, MAP and blood-gas tensions were measured after a 30-min equilibration period. Inspired oxygen fraction was increased from 0.4 to 1.0 for 10 min and then returned to baseline levels. Samples for arterial blood-gas measurements were obtained under baseline conditions and during oxygen ventilation.
Data are reported as mean (SD). Differences in mean values between the three groups were analysed by analysis of variance with post hoc testing if a significant F value was found. Differences between baseline and oxygen administration were analysed using paired t tests. If data distribution failed the underlying assumptions for normality and equal variance, non-parametric analyses using Kruskal-Wallis or Wilcoxon tests were performed.
Results
Under baseline conditions, the physiological variables in table 1 Figure 2 Tissue PO 2 during baseline measurements (Base) and oxygen ventilation (O 2 ). Baseline PO 2 was greater in controls compared with those with cerebral occlusive disease and AVM. The increase in PO 2 during hypoxia was attenuated in cerebral occlusive disease and AVM compared with controls. *P:0.05 compared with baseline; †P:0.05 compared with control. Figure 1 Changes in PO 2 , PCO 2 and pH during oxygen ventilation in a non-ischaemic patient. The scale for PO 2 and PCO 2 (kPa) is shown on the left and that for pH on the right. Oxygen ventilation produced an increase in PO 2 with no change in PCO 2 or pH.
Discussion
In non-ischaemic patients, we found a baseline tissue PO 2 of 4.2 kPa. This is consistent with previous reports. 1-3 8 During hyperoxia, tissue PO 2 increased to 7.5 kPa in non-ischaemic patients. This agrees with the conclusions of Meixenberger and colleagues 3 that local mechanisms regulate the upper limit of tissue oxygenation. Tissue oxygenation decreased significantly in patients with cerebral occlusive disease and AVM under baseline conditions and during oxygen ventilation. This indicates that mechanisms which promote tissue oxygenation are attenuated in occlusive disease and AVM.
Previous studies have suggested that cerebral occlusive disease and AVM produce different types of ischaemia. Acute and chronic brain ischaemia during brain artery occlusion is associated with a decrease in PO 2 , an increase in PCO 2 and acidosis. 1 8-11 This is accompanied by loss of cerebrovascular reactivity to increases in 2 CO a P . 12 In contrast, with an AVM, cerebral tissue perfusion pressure and blood flow are decreased because of shunting of arterial blood flow away from normal tissue. 4-6 13 Although AVM have been described as producing vascular paralysis and ischaemia, 14 studies have shown that carbon dioxide reactivity and pressure autoregulation are intact. 5 6 In spite of the reported differences between these two types of ischaemia, we found that the tissue oxygenation response to oxygen ventilation was attenuated in both groups. This suggests that inadequate brain tissue oxygen delivery is a consistent problem in patients with cerebral occlusive disease and AVM.
In this study, patients with occlusive disease had significantly increased tissue PCO 2 and decreased pH. This supports previous reports that carbon dioxide clearance is attenuated and metabolic acidosis may be present in these regions. 9 11 15 16 In contrast, in tissue adjacent to an AVM, PCO 2 and pH did not differ from control values, possibly because decreased tissue metabolism would lower carbon dioxide production and normalize pH in hypoxic tissue. 17 One concern is that the lack of change in brain tissue PCO 2 and pH results from a lack of sensitivity of the sensors rather than absence of a tissue change. However, in previous studies we have shown that tissue PCO 2 and pH change in patients during hypercapnic challenge. 9 This supports the fact that the lack of changes in tissue PCO 2 and pH during increases in oxygen ventilation were accurate.
In summary, these results showed that brain tissue PO 2 was lower in patients with cerebral occlusive disease and AVM compared with non-ischaemic patients. During oxygen ventilation, tissue PO 2 increased (4.6 kPa) in control patients; this was significantly greater than the response in patients with occlusive disease and AVM. Simultaneous measurements of tissue PCO 2 and pH indicated that the metabolic characteristics of occlusive disease and AVM were different but that inadequate tissue oxygenation was a consistent problem in both groups.
